Integra LifeSciences Holding Company (NASDAQ: IART), a global leader in medical technology, has released its latest Environmental, Social, and Governance (ESG) report. The 2023 report outlines the company’s performance and progress in these areas over the past year, following the ESG strategy established three years ago.
The report covers the recalculation of Scope 1, 2, and 3 emissions and collaboration with an external consultant to assess energy usage at key locations, aiming to reduce energy consumption and improve the company’s greenhouse gas footprint.
Social initiatives included the launch of a new employee resource group and an enhanced focus on early-career talent, providing support and hands-on experience to diverse college students and graduates.
Governance efforts involved updating the Code of Conduct and strengthening the anti-bribery and corruption program with ongoing training and development. The report aligns with the Global Reporting Index and the Sustainability Accounting Standards Board Index.